medigraphic.com
ISSN 1029-3035 (Electronic)

2019, Number 1

<< Back Next >>

Mediciego 2019; 25 (1)

Late cardiotoxicity by anthracyclines used for treatment of acute lymphoblastic leukemia in pediatric age

Puentes IY, García LV, Betancourt VM, Plá TMJ, Oliva CCM, López LS

Language: Spanish
References: 15
Page: 4-12
PDF size: 121.46 Kb.


ABSTRACT

Introduction: the acute lymphoblastic leukemias diagnosed in prediatric age are treated with anthracyclines which offers good results. However, these drugs produce cardiotoxicity, which limits their use.
Objective: to identify the subclinical alterations of late cardiotoxicity caused by anthracyclines used in patients with acute lymphoblastic leukemia in pediatric age.
Method: a preexperiment was carried out with post-test between September 2015 and December 2016. The population under study was constituted by the 18 patients treated in the Oncology Department of the Pediatric Hospital in Camagüey, who underwent an electrocardiogram and twodimensional echocardiogram, Doppler and color flow, and calculated the cumulative dose of anthracyclines in mg/m2 of body surface area.
Results: the female sex predominated (61,11%), almost all patients were 10 or more years old, 83,33 % showed signs of late cardiotoxicity. Electrocardiographic alterations prevailed (86,67 %) due to sinus tachycardia, on echocardiography (13,33%) due to an increase in diastolic diameter of the left ventricle. Cardiotoxicity was identified even in those who received the lowest dose (180 mg/m2 and 240 mg/m2) and in all those who received the treatment for two years or more. The echocardiographic signs appeared with the highest doses (600 mg/m2 to 720 mg/m2) while the electrocardiographic signs appeared for the other doses of the drug.
Conclusions: the electrocardiographic alterations prevailed over echocardiography. Cardiotoxicity occurred even when the time of exposure to the drug was short and the doses were low.


REFERENCES

  1. Paredes Aguilera R. Efectos tardíos del tratamiento antileucémico. Programa educativo: simposium leucemia aguda. Rev Hematol. May 2010;11 Supl 1:4-11.

  2. Vormoor J, Chintagumpala M. Leukaemia and cancer in neonates. Semin Fetal Neonatal Med [Internet]. Ago 2012 [citado 11 Nov 2012];17(4):183-4. Disponible en: https://www.sfnmjournal.com/article/S1744-165X(12)00053-4/pdf

  3. Losada Buchillón R, Dorticós Balea E, Porto González DE, Abreu Consu J, Valiente Mustelier J, Espinosa Martínez E, et al. Cardiotoxicidad en pacientes con leucemia aguda promielocítica tratados con altas dosis de antraciclinas. Rev Cubana Hematol Inmunol Hemoter [Internet]. Dic 2003 [citado 11 Dic 2014];19(2-3):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-02892003000200008&script=sci_arttext&tlng=en

  4. Parma G, Lluberas N, Castillo C, Ormaechea G. Quimioterápicos y Cardiotoxicidad: un enfoque actual y práctico para el clínico de una disciplina en pleno desarrollo. Arch. Med Int [Internet]. Jul 2013 [citado 11 Dic 2014];35(2):37-47. Disponible en: http://www.scielo.edu.uy/pdf/ami/v35n2/v35n2a03.pdf

  5. Chibuzor Nwuruku G, Prohías Martínez JA, Castro Arca AM, Mérida Álvarez O, Brooks Tamayo J, García Hernández RA. Detección precoz de cardiotoxicidad inducida por antraciclinas. CorSalud [Internet]. Sep 2014 [citado 11 Dic 2014];6(3):229-34. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/download/280/562

  6. Cedré Hernández T, Martínez Cárdenas L, García Caraballoso MB, González Díaz A, González Ojeda G, Castillo Villocht A. Cardiotoxicidad tardía por antraciclinas en pacientes tratados por leucemia linfoblástica aguda infantil. Acta Médica del Centro [Internet]. 2013 [citado 10 May 2017];7(3):[aprox. 5 p.]. Disponible en: http://www.medigraphic.com/pdfs/medicadelcentro/mec-2013/mec133d.pdf

  7. Park MK. Evaluación cardíaca habitual en niños. En: Park MK. Manual Práctico de Cardiología Pediátrica. 2da ed. San Diego: Harcourt Brace; 1999. p. 57-63.

  8. Ylänen K, Poutanen T, Savukoski T, Eerola A, Vettenranta K. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines. Acta Paediatr [Internet]. Mar 2015 [citado 27 Jul 2016];104(3):313-9. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1111/apa.12862

  9. Lax J, Piñeiro D. Consenso de diagnóstico, prevención y tratamiento de la cardiotoxicidad por tratamiento médico del cáncer. Rev Argent Cardiol [Internet]. Dic 2013 [citado 15 Oct 2014];81(6):530-6. Disponible en: https://www.redalyc.org/pdf/3053/305329421012.pdf

  10. Franco VI, Lipshultz SE. Cardiac complications in childhood cancer survivors treated with anthracyclines. Cardiol Young. Ago 2015;25 Supl 2:107-16.

  11. Baró Rojas M, Sánchez González EL, García Sotolongo W. Cardiotoxicidad por Antraciclinas. Presentación de un caso. MediCiego [Internet]. 2013 [citado 10 May 2017];19 Supl 2:[aprox. 8 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mciego/vol19_supl2_2013/pdf/T16.pdf

  12. Cochrane Database of Systematic Reviews, Issue 9, 2014. [base de datos en Internet]. Oxford: Update Software Ltd; 1998- [citado 10 May 2017]. Van Dalen EC, Raphaël MF, Caron HN, Kremer LC. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer (Revisión Cochrane) CD006647. [aprox. 75 p.]. Disponible en: https://dyz6l42c0kkca.cloudfront.net/articles/downloaded/cochrane/8f603df89fc99d9b73e4c8 46d0c62baadde63a1eee5b61d18ee3b3f1a207d8b7.pdf?response-contentdisposition= attachment%3Bfilename%3D%22Dalen_et_al-2014- Cochrane_Database_of_Systematic_Reviews.pdf%22&Expires=1552521600&Signature=NfYR O7L35BeYDlXqbJ9L7H~YM9JuOxgXxexk~ 19m~JUf9TJ1mMpGVhz3S0hXqWu4geWn5a9h4Zmy8dTakZLy7qqgzKF2rc2pAoQS~- NIEGYUY7-sDgARl7sdvWC3jW4zbAIO0LbtVbCSyRFjL8Fzk0W0XFLUZ~KHvPUuNqghpY_&Key- Pair-Id=APKAI2AQJBOTGLBL6N3A

  13. Navarrete Hurtado S, Castellanos Mejía AM, Chaparro Sanabria A. Cardiotoxicidad por quimioterapia. Un enfoque práctico para el clínico. Insuf. Card [Internet]. 2011 [citado 10 May 2017];6(3):131-43. Disponible en: http://ppct.caicyt.gov.ar/index.php/ic/article/viewFile/1009/910

  14. Navarrete Rodríguez EM, Zapata Tarrés MM, Vizcaíno Alarcón A, Garduño Espinosa J, Dorantes Acosta E, Palomo Colli MA. El ecocardiograma y su papel en niños con cáncer. Bol. Med. Hosp. Infant. Mex. [Internet]. Abr 2013 [citado 10 May 2017];70(2):133-7. Disponible en: http://www.scielo.org.mx/pdf/bmim/v70n2/v70n2a9.pdf

  15. Iarussi D, Galderisi M, Ratti G, Tedesco MA, Indolfi P, Casale F, et al. Left ventricular systolic and diastole function after anthacycline chemotherapy in childhood. Clin. Cardiol [Internet]. Oct 2001 [citado 10 May 2017];24(10):663-9. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.4960241006




2020     |     www.medigraphic.com